Pirfenidone Capsule
Product Images NDC 69097-940

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 69097-940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pirfenidone 01)

Chemical structure of Pirfenidone showing a pyridone ring bonded to a phenyl ring with a methyl group attached to the pyridone ring.*

FDA Label Image

Figure 1 (Pirfenidone 02)

A cumulative distribution plot comparing percentage of patients for Pirfenidone versus placebo groups based on absolute change in percent predicted forced vital capacity (%FVC) from baseline to week 52. The x-axis shows change in %FVC, from -30% to +10%, with the graph delineated between worsening (decrease in %FVC) and no decline (increase in %FVC). The y-axis shows percentage of patients from 0% to 100%. Two lines represent Pirfenidone (solid) and placebo (dotted) groups, illustrating differences in patient outcomes over time.*

FDA Label Image

Figure 2 (Pirfenidone 03)

Line graph depicting mean change in forced vital capacity (FVC) over 52 weeks comparing Pirfenidone and placebo groups. The y-axis shows mean change in FVC (mL), and the x-axis shows time in weeks. The Pirfenidone group exhibits a less steep decline in FVC compared to placebo over the study period.*

FDA Label Image

Figure 3 (Pirfenidone 04)

A Kaplan-Meier survival curve chart showing the percentage of patients alive over time in weeks for two groups: Pirfenidone (n=623) and Placebo (n=624). The chart includes a hazard ratio (HR) with 95% confidence interval (CI) and displays patient counts at risk across multiple time points up to 120 weeks.*

FDA Label Image

Principal Display Panel (90 Capsules)

Label for Pirfenidone Capsules 267 mg from Cipla USA Inc. This bottle contains 90 oral capsules. The label includes dosage strength, manufacturer information, storage instructions, barcode, and the note 'No Varnish' on the right side.*

FDA Label Image

Principal Display Panel (270 Capsules)

Label for Pirfenidone Capsules 267 mg, a human prescription drug in oral capsule form. The label indicates a packaging size of 270 capsules. Manufactured for Cipla USA Inc. and produced by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, barcode, and branding with the Cipla logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.